TFRC and synovial sarcoma: Moreover, transferrin receptor 1 (TFRC) and SHANK-associated RH domain interactor (SHARPIN), both of which are oncogenic factors and related to poor overall survival, are highly expressed, particularly in synovial sarcoma cell lines.